<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

FDA approves Merck’s Keytruda Qlex for solid tumor indications

PremiumThe Fly

2d ago

Merck receives positive EU CHMP opinion for Enflonsia

PremiumThe Fly

2d ago

Merck receives two positive EU CHMP opinions for Keytruda

PremiumThe Fly

2d ago

General Mills reports Q1 beat, Rithm to acquire Paramount Group: Morning Buzz

PremiumThe Fly

4d ago

PremiumThe FlyNetflix upgraded, Five Below initiated: Wall Street’s top analyst calls

4d ago

Merck downgraded to Hold from Buy at Berenberg

The Fly

Merck downgraded to Hold from Buy at Berenberg

4d ago

Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots

AstraZeneca pauses planned $270M investment in Britain, Reuters reports

The Fly

Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots

9d ago

PremiumThe Fly

9d ago

Merck’s capvaxive shows positive immune response in pneumococcal disease

PremiumThe Fly

10d ago

Merck’s Strategic Advantage in ADCs for ES-SCLC: A Buy Rating by Daina Graybosch

PremiumRatings

10d ago

Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads

PremiumThe Fly

11d ago

PremiumThe FlyMerck scraps London drug research center, cuts 125 staff, FT reports

11d ago

Omnicom, WPP under pressure after Trump moves to regulate pharma ads

The Fly

Omnicom, WPP under pressure after Trump moves to regulate pharma ads

11d ago

BMY

Trump Trade: U.S. President signs new pharma order

The Fly

Trump Trade: U.S. President signs new pharma order

11d ago

Trump signs memorandum mandating pharma ads give more info on risks

PremiumThe Fly

11d ago

Merck & Co. Closes $6 Billion Notes Offering

BMY

PremiumCompany Announcements

12d ago

Daiichi, Merck announce results from phase 2 trial of ifinatamab deruxtecan

PremiumThe Fly

14d ago

Guggenheim starts Summit Therapeutics at Buy, sees ‘multi-fold upside potential’

PremiumThe Fly

17d ago

SMMT

PremiumThe FlyMerck’s enlicitide decanoate meets primary and secondary Phase 3 endpoints

19d ago

Merck’s VICTOR trial did not reach statistical significance for primary endpoint

The Fly

Merck’s VICTOR trial did not reach statistical significance for primary endpoint

20d ago

Merck & Company’s Positive Clinical Trial Results and Strategic Positioning Drive Buy Rating

Ratings

Merck & Company’s Positive Clinical Trial Results and Strategic Positioning Drive Buy Rating

24d ago